Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
26 août 2021 16h05 HE
|
Aadi Bioscience
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155 million PIPE financing is backed by leading life science investors led...
Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award
31 janv. 2020 02h30 HE
|
Helsinn Healthcare S.A.
Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award MONACO, PRINCIPALITY OF MONACO, AND NEW YORK, NY, USA, January 31, 2020:...
Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award
14 janv. 2020 08h00 HE
|
Helsinn Healthcare S.A.
Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award The Award recognizes Patient Entrepreneurs demonstrating outstanding...
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
17 sept. 2019 08h10 HE
|
Helsinn Healthcare S.A.
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology The Award recognizes Patient Entrepreneurs demonstrating...
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020
29 août 2019 08h00 HE
|
Helsinn Healthcare S.A.
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020 The Award recognizes Patient...
Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced
19 mars 2019 18h00 HE
|
Helsinn Healthcare S.A.
Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced Mihir Shah of UE LifeSciences Inc. has been selected as the winner of the 2019 Lyfebulb-Helsinn...
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
06 mars 2019 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology
27 févr. 2019 08h15 HE
|
Helsinn Healthcare S.A.
Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer...
Helsinn and Lyfebulb Announce Partnership for Second Annual Patient-Driven Innovation Summit in Cancer
27 nov. 2018 10h52 HE
|
Helsinn Healthcare S.A.
The award will be presented to the Patient Entrepreneur demonstrating outstanding science and potential to bring their idea to the market for cancer patients LUGANO, SWITZERLAND, AND NEW YORK, NY,...
Lyfebulb and UnitedHealth Group Announce Winners of the 2018 Innovation Challenge for Patient Entrepreneurs
26 juil. 2018 09h00 HE
|
Lyfebulb
MINNETONKA, Minn. and NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) have selected Jon Margalit of Complete Start as the winner of the first-ever Lyfebulb...